Combining Gene Expression Profiles and Clinical Parameters for Risk Stratification in Medulloblastomas
- 15 March 2004
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (6), 994-998
- https://doi.org/10.1200/jco.2004.03.036
Abstract
Purpose Stratification of risk in patients with medulloblastoma remains a challenge. As clinical parameters have been proven insufficient for accurately defining disease risk, molecular markers hav...Keywords
This publication has 28 references indexed in Scilit:
- Pre-validation and inference in microarraysStatistical Applications in Genetics and Molecular Biology, 2002
- Histopathologic grading of medulloblastomasCancer, 2002
- Prediction of central nervous system embryonal tumour outcome based on gene expressionNature, 2002
- Survival and recurrence factors in adult medulloblastoma: The M.D. Anderson Cancer Center experience from 1978 to 1998Neuro-Oncology, 2001
- C-MYC expression in medulloblastoma and its prognostic valueInternational Journal of Cancer, 2000
- Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumorsAnnals of Neurology, 1996
- Effects of Medulloblastoma Resections on Outcome in Children: A Report from the Children's Cancer GroupNeurosurgery, 1996
- Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International society of paediatric oncology (SIOP) and the (German) society of paediatric oncology (GPO): SIOP IIMedical and Pediatric Oncology, 1995
- A review of the factors influencing the prognosis of medulloblastomaJournal of Neurosurgery, 1987
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958